Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy

Area of Science:

• Biomedical science
• Cardiovascular research
• Inflammation biology

Background:

• Inflammation is central to atherosclerosis and its complications.
• Blood-based inflammation biomarkers may predict cardiovascular disease (CVD) risk.
• Established markers include C-reactive protein and fibrinogen.

Purpose of the Study:

• To explore the role of systemic inflammation markers in predicting cardiovascular disease.
• To investigate novel inflammation markers beyond C-reactive protein and fibrinogen.
• To examine inflammation's link to diverse cardiovascular phenotypes like stroke and atherosclerosis.

Main Methods:

• Review of existing literature on inflammation biomarkers and cardiovascular disease.
• Analysis of studies examining global inflammation markers (e.g., C-reactive protein, fibrinogen).
• Exploration of emerging markers: cytokines, adhesion molecules, and matrix degradation enzymes.

Main Results:

• Systemic inflammation markers show potential for predicting future cardiovascular events.
• Evidence links inflammation to myocardial infarction, ischemic stroke, and early atherosclerosis.
• Novel markers offer insights into complex inflammatory pathways.

Conclusions:

• Elucidating inflammation's role may reveal new preventive and therapeutic targets for CVD.
• Inflammation markers could monitor patient response to therapies like aspirin and statins.
• Further research is warranted to fully leverage inflammation markers in cardiovascular medicine.